(Q44342374)

2 December 2017

title

Binding characteristics of [3H]14-methoxymetopon, a high affinity mu-opioid receptor agonist (English)

1 reference

2 December 2017

0 references

Helmut Schmidhammer

8

0 references

author name string

Mariana Spetea

1

1 reference

2 December 2017

Fanni Tóth

2

1 reference

2 December 2017

Johannes Schütz

3

1 reference

2 December 2017

Ferenc Otvös

4

1 reference

2 December 2017

Géza Tóth

5

1 reference

2 December 2017

Sandor Benyhe

6

1 reference

2 December 2017

Anna Borsodi

7

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

European Journal of Neuroscience

2 December 2017

published in

1 reference

2 December 2017

volume

18

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

290-295

1 reference

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

14-methoxymetopon, a potent opioid, induces no respiratory depression, less sedation, and less bradycardia than sufentanil in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

Highly potent novel opioid receptor agonist in the 14-alkoxymetopon series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

14-Methoxymetopon, a very potent mu-opioid receptor-selective analgesic with an unusual pharmacological profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

[3H]U-69593 a highly selective ligand for the opioid kappa receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

The pharmacological basis of contemporary pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

Mu-opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [35S]GTPgammaS binding assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

Incomplete cross tolerance and multiple mu opioid peptide receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

Binding, pharmacological and immunological profiles of the delta-selective opioid receptor antagonist HS 378.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

In vitro binding and signaling profile of the novel mu opioid receptor agonist endomorphin 2 in rat brain membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

Interaction of agonist peptide [3H]Tyr-D-Ala-Phe-Phe-NH2 with mu-opioid receptor in rat brain and CHO-mu/1 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

G proteins and opioid receptor-mediated signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

Effects of 14-methoxymetopon, a potent opioid agonist, on the responses to the tail electric stimulation test and plus-maze activity in male rats: neuroendocrine correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

Receptor binding and biological activity of the dermorphin analog Tyr-D-Arg(2)-Phe-Sar (TAPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

Signal transduction efficacy of the highly potent mu opioid agonist 14-methoxymetopon

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

Tritiated kappa receptor antagonist norbinal torphimine: synthesis and in vitro binding in three different tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02744.X

10.1046/J.1460-9568.2003.02744.X

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference